Table 1

 Case-control study (GPRD) of hay fever and vaccinations

VaccineMonth(s) of lifeCounts (%) cases + controlsUnadjusted*Adjusted†Adjusted‡
OR95% CIp valueOR95% CIp valueOR95% CIp value
OR, odds ratio; 95% CI, 95% confidence interval.
*Unadjusted matched pairs analysis (4196 pairs for DTP and MMR, 4189 pairs for BCG).
†Adjusted for consultation frequency and restricted to pairs with non-ghost controls (3859 pairs for DTP and MMR, 3852 pairs for BCG).
‡Further adjusted for numbers of older and younger sibs and multiple births (3859 pairs for DTP and MMR, 3453 pairs for BCG).
Tests for trend (non-ghost control pairs and adjusted for consultation frequency).
DTP: 0.92 (0.87, 0.97), p = 0.003; MMR: 0.96 (0.92, 0.99), p = 0.02.
8392 (100)
DTPDTP3 1st–4th1087(13.0)0.910.78 to 1.060.220.940.78 to 1.120.480.900.75 to 1.080.26
DTP3 5th2786 (33.2)111
DTP3 6th1178 (14.0)1.010.87 to 1.170.881.060.89 to 1.270.501.100.92 to 1.310.31
DTP3 7th–9th1163 (13.9)0.780.66 to 0.920.0040.730.59 to 0.910.0040.800.64 to 0.990.04
DTP3 10th–12th1165 (13.9)0.750.60 to 0.940.010.850.64 to 1.130.270.930.70 to 1.240.63
DTP3 13th +482 (5.7)0.530.40 to 0.69<0.00010.580.41 to 0.810.0020.640.45 to 0.900.01
Other DTP183 (2.2)0.810.57 to 1.150.230.830.54 to 1.270.390.860.55 to 1.330.49
No DTP346 (4.1)0.900.70 to 1.160.420.910.66 to 1.260.561.010.73 to 1.330.95
MMR1st–13th1688 (20.1)1.000.86 to 1.160.970.980.82 to 1.180.840.970.81 to 1.160.74
14th2311 (27.5)111
15th1638 (19.5)0.840.73 to 0.970.020.880.74 to 1.040.130.890.75 to 1.060.19
16th1183 (14.1)0.920.77 to 1.090.340.930.76 to 1.150.500.930.75 to 1.140.48
17th510 (6.1)0.960.76 to 1.200.690.940.72 to 1.230.640.960.73 to 1.250.75
18th–24th618 (7.4)0.780.64 to 0.950.010.860.68 to 1.100.230.890.70 to 1.140.37
25th+234 (2.8)0.690.52 to 0.920.010.770.54 to 1.080.130.830.58 to 1.180.29
No MMR210 (2.5)0.590.42 to 0.820.0020.770.50 to 1.170.220.810.53 to 1.240.33
BCGBCG <2 y198 (2.4)1.390.99 to 1.950.061.250.85 to 1.850.261.360.91 to 2.050.14
No BCG/>2 y8180 (97.6)111